Paper3966985
A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
Bullard DE and 7 others. Br J Cancer, 1985. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. Papers, record 3966985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3966985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Brain Neoplasms | Major topic |
| Glioma | Major topic |
| HLA Antigens | Major topic |
| Immunotherapy | Major topic |
| Adult | |
| Antibodies, Neoplasm | |
| Cell Line | |
| Combined Modality Therapy | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1-31-CA 06680-01 | NCI NIH HHS | United States | PubMed | PubMed | |
| F32CA006680 | NIH | NIH RePORTER |
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6260907 | Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. | J Neuropathol Exp Neurol | 1981 | https://conductscience.org/library/papers/6260907 | PubMed |
| 2 | 88260 | Surface antigens of human glioma cells shared with normal adult and fetal brain. | Cancer Res | 1979 | https://conductscience.org/library/papers/88260 | PubMed |
| 3 | 6165811 | Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue. | J Neurosurg | 1981 | https://conductscience.org/library/papers/6165811 | PubMed |
| 4 | 7252525 | Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. | J Neuropathol Exp Neurol | 1981 | https://conductscience.org/library/papers/7252525 | PubMed |
| 5 | 7334081 | Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction. | J Neuroimmunol | 1981 | https://conductscience.org/library/papers/7334081 | PubMed |
| 6 | 6337710 | Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6337710 | PubMed |
| 7 | 6864286 | Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study. | J Neurosurg | 1983 | https://conductscience.org/library/papers/6864286 | PubMed |
| 8 | 6602866 | Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas. | J Neurosurg | 1983 | https://conductscience.org/library/papers/6602866 | PubMed |
| 9 | 6140656 | Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test. | Neurol Res | 1983 | https://conductscience.org/library/papers/6140656 | PubMed |
| 10 | 13801625 | Autologous glioma transplantation. | Lancet | 1960 | https://conductscience.org/library/papers/13801625 | PubMed |
| 11 | 4320802 | [Cellular immunotherapy of cerebral glioblastoma. Apropos of 2 results]. | J Med Lyon | 1969 | https://conductscience.org/library/papers/4320802 | PubMed |
| 12 | 4345108 | Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. | J Exp Med | 1972 | https://conductscience.org/library/papers/4345108 | PubMed |
| 13 | 4348472 | Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. | Br J Cancer | 1973 | https://conductscience.org/library/papers/4348472 | PubMed |
| 14 | 4350512 | [Delayed hypersensitivity reactions in patients bearing malignant brain tumors with human tumor cell lines grown in vitro]. | Int J Cancer | 1972 | https://conductscience.org/library/papers/4350512 | PubMed |
| 15 | 4367367 | [Immunology and immunotherapy of cerebral tumors. Current status]. | Rev Neurol (Paris) | 1973 | https://conductscience.org/library/papers/4367367 | PubMed |
| 16 | 769940 | Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors. | Cancer | 1976 | https://conductscience.org/library/papers/769940 | PubMed |
| 17 | 894339 | Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. | J Neurosurg | 1977 | https://conductscience.org/library/papers/894339 | PubMed |
| 18 | 330067 | Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/330067 | PubMed |
| 19 | 191575 | Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. | J Neurosurg | 1977 | https://conductscience.org/library/papers/191575 | PubMed |
| 20 | 198084 | Immunotherapy with autologous white cell infusions ("lymphocytes") in the treatment of recurrrent glioblastoma multiforme: a preliminary report. | Cancer | 1977 | https://conductscience.org/library/papers/198084 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19591631 | The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. | Expert Opin Biol Ther | 2009 | https://conductscience.org/library/papers/19591631 | PubMed |
| 18539480 | Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma. | Semin Immunol | 2008 | https://conductscience.org/library/papers/18539480 | PubMed |
| 15279716 | Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. | Neuro Oncol | 2004 | https://conductscience.org/library/papers/15279716 | PubMed |
| 1744686 | Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy. | J Neurooncol | 1991 | https://conductscience.org/library/papers/1744686 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3966985
GET https://conductscience.org/api/papers/v1/3966985/references?page=2